Cytologic diagnosis of papillary renal neoplasm with reverse polarity
- 11 September 2024
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 133 (1) , e22903
Abstract
Background: Papillary renal neoplasm with reverse polarity is a recently recognized low‐grade neoplasm with a favorable prognosis. To date, its cytologic features have not been well documented.Methods: Two patients with papillary renal neoplasm with reverse polarity sampled by fine needle aspiration and core needle biopsy are described, one of whom is under active surveillance without clinical progression and the other is alive and well 16 years after partial nephrectomy.Results: The cytologic features included a mix of papillae and dispersed cells with abundant oncocytic cytoplasm and round, bland nuclei apically displaced away from the papillary core. Immunohistochemistry showed positive staining for GATA3 in both cases. Molecular studies on one of the cases showed a KRAS p.G12V mutation.Conclusions: The cytologic features of this distinctive, indolent neoplasm are important to recognize because patients with papillary renal neoplasm with reverse polarity may be excellent candidates for partial nephrectomy or even active surveillance.Keywords
This publication has 19 references indexed in Scilit:
- Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 casesPathology - Research and Practice, 2024
- Low‐risk oncocytic renal neoplasm: A useful cytologic diagnosisCancer Cytopathology, 2023
- How New Developments Impact Diagnosis in Existing Renal NeoplasmsSurgical Pathology Clinics, 2022
- Papillary renal neoplasm with reverse polarity—a comparative study with CCPRCC, OPRCC, and PRCC1Human Pathology, 2022
- Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinomaHuman Pathology, 2022
- Papillary renal cell carcinoma: current and controversial issuesCurrent Opinion in Urology, 2022
- ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar gradeHuman Pathology, 2022
- Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarityHuman Pathology, 2021
- Cytomorphology, immunoprofile, and management of renal oncocytic neoplasmsCancer Cytopathology, 2020
- Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular featuresHuman Pathology, 2008